ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,437,000 | +35.0% | 60,000 | +6.1% | 0.00% | +100.0% |
Q1 2023 | $1,064,366 | +127.9% | 56,555 | +182.8% | 0.00% | – |
Q4 2021 | $467,000 | -89.8% | 20,000 | -82.0% | 0.00% | -100.0% |
Q3 2020 | $4,588,000 | +28575.0% | 111,217 | +10846.6% | 0.00% | – |
Q4 2018 | $16,000 | -98.3% | 1,016 | -97.8% | 0.00% | -100.0% |
Q3 2018 | $964,000 | +35.6% | 46,493 | -0.1% | 0.00% | 0.0% |
Q2 2018 | $711,000 | -56.7% | 46,542 | -36.3% | 0.00% | -50.0% |
Q1 2018 | $1,643,000 | +9027.8% | 73,100 | +11942.8% | 0.00% | – |
Q4 2017 | $18,000 | -99.4% | 607 | -99.3% | 0.00% | -100.0% |
Q3 2017 | $3,070,000 | +23.4% | 81,482 | -8.6% | 0.01% | +25.0% |
Q2 2017 | $2,488,000 | -20.9% | 89,196 | -20.7% | 0.00% | -42.9% |
Q1 2016 | $3,146,000 | – | 112,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |